The current financial score of ICU Medical Inc is 8.20. Its financial status is stable, and its operating efficiency is high. Its latest quarterly revenue reached 551.68M, representing a year-over-year increase of 0.51%, while its net profit experienced a year-over-year increase of 45.99%.
The current valuation score of ICU Medical Inc is 7.60. Its current P/E ratio is 83.36, which is 6240.45% below the recent high of 5285.43 and 728.09% above the recent low of -523.58.
The current earnings forecast score of ICU Medical Inc is 8.86. The average price target is 195.57, with a high of 210.00 and a low of 187.00.
The current price momentum score of ICU Medical Inc is 3.65. Currently, the stock price is trading between the resistance level at 178.57 and the support level at 145.11, making it suitable for range-bound swing trading.
The current institutional shareholding score of ICU Medical Inc is 10.00. The latest institutional shareholding proportion is 114.41%, representing a quarter-over-quarter decrease of 3.95%. The largest institutional shareholder is Joel Greenblatt, holding a total of 19.29K shares, representing 0.01% of shares outstanding, with 48.93% decrease in holdings.
The current risk assessment score of ICU Medical Inc is 7.08. The company's beta value is 0.78. This indicates that the stock tends to underperform the index during upward trending markets but experiences smaller declines during downward trending markets.